Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 74-76, January 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cortes, E. P.
Right arrow Articles by Depoli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cortes, E. P.
Right arrow Articles by Depoli, E.

Effects of Mithramycin on Bone Resorption in Vitro1

Engracio P. Cortes, James F. Holland, Robert Moskowitz and Euro Depoli

Department of Medicine A, Roswell Park Memorial Institute, Buffalo, New York 14203

Embryonic rat bones labeled with 45CaCl2 are stimulated in vitro by parathyroid extract to release 45Ca. Mithramycin prevents this active release over a broad range of dose levels that are nonlethal to the bones, as evidenced by their subsequent responsiveness to additional parathyroid extract. The similarity of dose levels used to concentrations (based on calculated dilution) after clinical administration supports the interpretation that clinical effects of mithramycin in hypercalcemic patients are due to a direct effect on bone.

1 This investigation was supported by USPHS Grant Ca-5834 from the National Cancer Institute.

Received 7/21/71. Accepted 9/15/71.




This article has been cited by other articles:


Home page
ScienceHome page
M Segerling, S. Ohanian, and T Borsos
Chemotherapeutic drugs increase killing of tumor cells by antibody and complement
Science, April 4, 1975; 188(4183): 55 - 57.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.